Skip to search formSkip to main contentSkip to account menu

salmeterol

Known as: Salmaterol, Salmeterolum 
A highly selective, long-acting beta-2 adrenergic agonist with bronchodilatory activity. Salmeterol's benzene moiety resembles the structure of… 
National Institutes of Health

Related topics

Related topics

15 relations
28 ACTUAT salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Serevent]Acute DiseaseAdrenergic beta2-Agonists [MoA]Asthma

Narrower (3)

AdvairSalmeterol xinafoateSerevent

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1999
Highly Cited
1999
Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma.
The development of tolerance to the bronchodilator effects of beta2-agonists used in asthma therapy has been the subject of… 
1999
1999
Effect of a single dose of salmeterol on the increase in airway eosinophils induced by allergen challenge in asthmatic subjects
BACKGROUND The long acting β2 agonist salmeterol is very effective in preventing asthmatic responses to specific stimuli, and… 
1998
1998
Short-term cardiovascular effects of salmeterol.
The occurrence of cardiovascular side effects is sometimes associated with the utilization of beta-adrenoceptor agonists. The… 
1998
1998
Cost-Effectiveness Analysis of Formoterol Versus Salmeterol in Patients with Asthma
AbstractObjective: The aim of this study was to determine the relative economic consequences of treating asthmatics with twice… 
Highly Cited
1996
Highly Cited
1996
Tolerance to the protective effect of salmeterol on allergen challenge.
Long-term treatment with inhaled beta 2-agonists may be associated with a deterioration in asthma control, potentially due to… 
1995
1995
Inhaled salmeterol and albuterol in asthmatic patients receiving high-dose inhaled corticosteroids.
Salmeterol may be useful in the treatment of asthmatic patients requiring high-dose inhaled steroids, and there have been debates… 
1995
1995
Salmeterol inhaler using a non-chlorinated propellant, HFA134a: systemic pharmacodynamic activity in healthy volunteers.
BACKGROUND--Metered dose inhalers for the treatment of asthma use chlorofluorocarbons as propellants. These face an international… 
1994
1994
Bronchoprotection by salmeterol: cell stabilization or functional antagonism? Comparative effects on histamine- and AMP-induced bronchoconstriction.
Salmeterol provides bronchoprotection against a number of constrictor stimuli for more than 12 h after a single dose. This effect… 
1994
1994
TA-2005, a novel, long-acting, and selective beta 2-adrenoceptor agonist: characterization of its in vivo bronchodilating action in guinea pigs and cats in comparison with other beta 2-agonists.
Relaxant effects of the beta 2-selective adrenoceptor agonist TA-2005 on bronchoconstriction in the anesthetized guinea pig and… 
1993
1993
Bronchodilator treatment in asthma. Increase in deaths during salmeterol treatment unexplained.
EDITOR,-Win Castle and colleagues from Glaxo and Allen and Hanbury's describe the results of a large randomised clinical trial of…